more general categories
information about this item
03. Biological Effects of Specific Chemicals
03. Biological Effects of Specific Chemicals
ivacaftor [CHEBI:66901] (1)
05. Industrial Uses
05. Industrial Uses
ivacaftor [CHEBI:66901] (1)
08. Chemical Category
08. Chemical Category
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ivacaftor [CHEBI:66901] (1)
ChEBI Compound Accession Identifier :
[CHEBI:66901]
ChEBI Compound Description :
A carboxamide obtained by formal condensation of the carboxy group of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid with the amino group of 5-amino-2,4-di-tert-butylphenol. Used for the treatment of cystic fibrosis.
ChEBI Compound Identification Number :
66901
ChEBI InChI Value :
InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)
ChEBI InChIKey Value :
PURKAOJPTOLRMP-UHFFFAOYSA-N
ChEBI Compound Name :
ivacaftor
ChEBI SMILES Value :
CC(C)(C)c1cc(c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O)C(C)(C)C
ChEBI Substance ID :
160645564
ChEBI URL :
ChEBI:66901
ChemSpider ID :
17347474
Ontomatica Chemical Accession Key (OnChAKey) :
PURKAOJPTOLRMP_UHFFFAOYSA_N_000_000000
PubChem Compound ID :
16220172